|ZYGO Receives Order in Excess of $3 Million From Major Medical Device Company for High Precision Lens Assemblies|
MIDDLEFIELD, Conn., Apr 12, 2012 (GlobeNewswire via COMTEX) --Zygo Corporation (Nasdaq:ZIGO), a worldwide supplier of optical metrology instruments and high precision optical systems, today announced that its Optics business segment was awarded an order in March valued at more than $3 million by a major medical device company to produce high precision lens assemblies. The order will be manufactured by ZYGO's Electro-Optics group in its Tucson, Arizona and Costa Mesa, California facilities.
"Design and manufacture of complex high precision objective lenses across many markets is one of ZYGO's core competencies," stated John Stack, President of ZYGO's Optics business segment. "Our Electro-Optics group's FDA registration and strict adherence to ISO 13485 medical device standards, combined with their precision manufacturing capabilities, establish ZYGO as a manufacturer of choice for medical device companies seeking proven quality standards."
Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics, and electro-optical design and manufacturing services serving customers in the semiconductor capital equipment, bio-medical, scientific and industrial markets.
The Zygo Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10822
All statements other than statements of historical fact included in this news release regarding financial performance, condition and operations and the business strategy, plans, anticipated revenues, bookings, market acceptance, growth rates, market opportunities and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements provide management's current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as "anticipate," "believe," "estimate," "expect," "intend," "plan(s)," "strategy," "project," "should" and other words of similar meaning in connection with a discussion of future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending of our customers; fluctuations in revenues to our major customers; manufacturing and supplier risks; risks of booking cancellations, push-outs and de-bookings; dependence on timing and market acceptance of new product development; rapid technological and market change; risks in international operations; risks related to the reorganization of our business; dependence on proprietary technology and key personnel; length of the revenue cycle; environmental regulations; investment portfolio returns; fluctuations in our stock price; the risk that anticipated growth opportunities may be smaller than anticipated or may not be realized; risks related to business acquisitions, including the acquisition of substantially all the assets of ASML US, Inc.'s Richmond, California facility, and integration of the business and employees; the risks related to the Company's recent changes in senior management; and the risks associated with the recovery from the recent earthquake, tsunami and nuclear disaster in Japan and their impact on our customers, suppliers, and operations. Zygo Corporation undertakes no obligation to publicly update or revise forward-looking statements to reflect events or circumstances after the date of this news release except as required by law. Further information on potential factors that could affect Zygo Corporation's business is described in our reports on file with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2011, filed with the Securities and Exchange Commission on September 13, 2011.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Zygo Corporation
CONTACT: John P. Jordan
|Microscopy & µanalysis||08/06|
|ASPE Annual Meeting||11/06|
|MRS Fall Meeting||11/27|
|(Click for a complete list)|